ÄÔÊÒÖÜΧ°×ÖÊÈí»¯,periventricular leukomalaciaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Õý³£²Î¿¼Öµ,Normal reference valueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÎÑ׿ËÀײ®¸Ë¾ú,Klebsiella pneumoniaeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔѪ˨,cerebral thrombosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
̵֤,Phlegm syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²ñºúÔíÜÕa,saikosaponin aÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÎ÷À¼ÍÃ,New Zealand rabbitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ðÆ÷ÉË,Firearm woundÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÉÏËάϸ°û,Cardiac fibroblastsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×µ-»ùµ×¶¯Âö¹©Ñª²»×ã,Vertebrobasilar insufficiencyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞ¾úÐÔËɶ¯,Aseptic looseningÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹Üͨ·,Vascular accessÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼±ÐÔÉöС¹Ü»µËÀ,Acute tubular necrosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¡Àí¸Ä±ä,pathological changesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔÎ»ÒÆÖ²,orthotopic transplantationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÎǺÏ,vascular anastomosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×ÁöÄ£ÐÍ,Tumor modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼õѹ²¡,decompression sicknessÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼±ÐÔÐÄÁ¦Ë¥½ß,acute heart failureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Òìλ¹Ç»¯,heterotopic ossificationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¨¹Ì´¼õ¥×ªÔ˵°°×,cholesteryl ester transfer proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Èںϵ°°×ÖÊÀà,fusion proteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½ÇĤɢ¹â,corneal astigmatismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë®ºÏÂÈÈ©,chloral hydrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖÐÒ©¸´·½,Chinese herbal compoundÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöËðÉË,renal injuryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë«ÖØPCR,Duplex PCRÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÄÚÆ¤×æÏ¸°û,endothelial progenitor cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʵÑéÐÔ×ÔÉíÃâÒßÐÔÖØÖ¢¼¡ÎÞÁ¦,Experimental autoimmune myasthenia gravisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÒ±ÚÁö,Ventricular aneurysmÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½á³¦ºÚ±ä²¡,Melanosis coliÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÛÖ×Áö,Eye neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µç×迹,electrical impedanceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
àßøËá,quinolinic acidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»îÌå¸ÎÒÆÖ²,Living donor liver transplantationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´óÄÔÖж¯Âö×èÈû,middle cerebral artery occlusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Âé×í»Ö¸´ÆÚ,Anesthesia recovery periodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¡Ö¤½áºÏ,combination of disease and syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ESR»ùÒò,ESR geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐÔÅųⷴӦ,chronic rejectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
÷¿°å,epiphyseal plateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐÔ¹ÇËèÑ×,Chronic osteomyelitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÄò²¡Ð¡±ä,diabetic cardiomyopathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë¥ÀÏÄ£ÐÍ,Aging modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼±ÐÔµÍÑõ,acute hypoxiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÇÐÎ̬·¢Éúµ°°×,Bone morphogenetic proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
賦¼¤ËØ,gastrointestinal hormoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸´ºÏÂé×í,combined anesthesiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Í·Ó°²âÁ¿·ÖÎö,cephalometric analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
K562/A02ϸ°û,K562/A02 cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×Ô·¢ÐÔ¸ßѪѹ,Spontaneous HypertensionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÕ±¾ÑªÎü³æ²¡,Schistosomiasis japonicaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ѪҺÉú»¯,Blood BiochemistryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉÏò¢Ç°Ç£Òý,maxillary protractionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹Ú×´ñ¼,Coronary sinusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÔàÒÆÖ²,renal transplantationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
UWÒº,UW solutionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éö×éÖ¯,Renal TissueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´óÊóѪ½¬,rat plasmaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CT¹à×¢,CT perfusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½ü½»BALB/c,inbred BALB/cÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¹ÖùÖ×Áö,Spinal neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾±¾²Âö,jugular veinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Âö³åÔëÉù,Impulse noiseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CO2Æø¸¹,CO2 pneumoperitoneumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÌÑø²ãϸ°û,trophoblastÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾²Âöñ¼,venous sinusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÓÛÊäÄò¹ÜÁ¬½Ó²¿¹£×è,Ureteropelvic junction obstructionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÅÉäÐÔËðÉË,Radiation injuryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÑԲϸ°û,Oval cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞëСÊó,hairless miceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ä£ÐÍÆÀ¼Û,model evaluationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½Ç¼ÓËÙ¶È,angular accelerationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½ðÊôµ°°×ø1×éÖ¯ÒÖÖÆ¼Á,Tissue-inhibitor of metalloproteinase-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Bϸ°ûÁܰÍÁö,B cell lymphomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ñÐÔÐØÄ¤¼äƤÁö,Malignant pleural mesotheliomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÐΪÃô»¯,Behavioral sensitizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÄò²¡Ä£ÐÍ,diabetic modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
賦Ô˶¯,Gastrointestinal motilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºËØÃô¸ÐÐÔÖ¸Êý,insulin sensitivity indexÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½ºÔÓÕµ¼ÐԹؽÚÑ×,Collagen-induced arthritisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐԽ᳦Ñ×,chronic colitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¦Õ³Ä¤Í¨Í¸ÐÔ,intestinal permeabilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ó¦Á¦ÐÔ¹ÇÕÛ,Stress fractureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´Ù»ÆÌåÉú³ÉËØ,luteinizing hormoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ëë×°±ËáÌ춬°±Ëáµ°°×ø3,Caspase-3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Î±£»¤,Lung protectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»·ºËÜÕËá,cyclic nucleotideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇòÄÒµ¼¹Ü,Balloon catheterÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÕûºÏËØ¦Áv¦Â3,integrin ¦Áv¦Â3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐÔÅųâ,chronic rejectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍÃÄ£ÐÍ,Rabbit modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÚÄòÉúֳϵͳ,urogenital systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂýÐÔ¸ßÑÛѹ,chronic ocular hypertensionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È˹ÇËè¼ä³äÖʸÉϸ°û,Human mesenchymal stem cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ÂÈøÆæ²¡¶¾B3,Coxsackievirus B3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼±ÐÔÑ×Ö¢,Acute inflammationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑôÐé,yang deficiencyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËÄÕï,four diagnostic methodsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ũ¶È¼«»¯,concentration polarizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|